Pyrimidine substituted purine compounds as kinase (S) inhibitors
US9138437B2 · kind B2 · utility
0Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2014 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | May 7, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a purine compound useful as a kinase inhibitor. The compound has the structure:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.